NO176609C - Fremgangsmåte til fremstilling av et sterkt vannlöselig, stabilt, krystallinsk salt av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin eller 2',3'dideoksy-2'-fluorinosin - Google Patents

Fremgangsmåte til fremstilling av et sterkt vannlöselig, stabilt, krystallinsk salt av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin eller 2',3'dideoksy-2'-fluorinosin

Info

Publication number
NO176609C
NO176609C NO933367A NO933367A NO176609C NO 176609 C NO176609 C NO 176609C NO 933367 A NO933367 A NO 933367A NO 933367 A NO933367 A NO 933367A NO 176609 C NO176609 C NO 176609C
Authority
NO
Norway
Prior art keywords
dideoxy
stable
hydrothymidine
fluorinosine
deideoxy
Prior art date
Application number
NO933367A
Other languages
English (en)
Other versions
NO933367L (no
NO933367D0 (no
NO176609B (no
Inventor
Murray Arthur Kaplan
Robert Kevin Perrone
Joseph Ballard Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO933367L publication Critical patent/NO933367L/no
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to NO933367A priority Critical patent/NO176609C/no
Publication of NO933367D0 publication Critical patent/NO933367D0/no
Publication of NO176609B publication Critical patent/NO176609B/no
Publication of NO176609C publication Critical patent/NO176609C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO933367A 1989-05-15 1993-09-22 Fremgangsmåte til fremstilling av et sterkt vannlöselig, stabilt, krystallinsk salt av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin eller 2',3'dideoksy-2'-fluorinosin NO176609C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO933367A NO176609C (no) 1989-05-15 1993-09-22 Fremgangsmåte til fremstilling av et sterkt vannlöselig, stabilt, krystallinsk salt av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin eller 2',3'dideoksy-2'-fluorinosin

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35206589A 1989-05-15 1989-05-15
US51426190A 1990-05-01 1990-05-01
NO902148A NO174102C (no) 1989-05-15 1990-05-15 Analogifremgangsmåte til fremst. av et terapeutisk aktivt, stabilt, krystallinsk vannopplöselig salt av 2',3'-dideoksyinosinmonohydrat, 2',3'-dideoksy-2',3'-didehydrotymidinmonohydrat og 2',3'-dideoksy-2'-fluorinosinhemihydrat
NO933367A NO176609C (no) 1989-05-15 1993-09-22 Fremgangsmåte til fremstilling av et sterkt vannlöselig, stabilt, krystallinsk salt av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin eller 2',3'dideoksy-2'-fluorinosin

Publications (4)

Publication Number Publication Date
NO933367L NO933367L (no) 1990-11-16
NO933367D0 NO933367D0 (no) 1993-09-22
NO176609B NO176609B (no) 1995-01-23
NO176609C true NO176609C (no) 1995-05-03

Family

ID=26997373

Family Applications (2)

Application Number Title Priority Date Filing Date
NO902148A NO174102C (no) 1989-05-15 1990-05-15 Analogifremgangsmåte til fremst. av et terapeutisk aktivt, stabilt, krystallinsk vannopplöselig salt av 2',3'-dideoksyinosinmonohydrat, 2',3'-dideoksy-2',3'-didehydrotymidinmonohydrat og 2',3'-dideoksy-2'-fluorinosinhemihydrat
NO933367A NO176609C (no) 1989-05-15 1993-09-22 Fremgangsmåte til fremstilling av et sterkt vannlöselig, stabilt, krystallinsk salt av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin eller 2',3'dideoksy-2'-fluorinosin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO902148A NO174102C (no) 1989-05-15 1990-05-15 Analogifremgangsmåte til fremst. av et terapeutisk aktivt, stabilt, krystallinsk vannopplöselig salt av 2',3'-dideoksyinosinmonohydrat, 2',3'-dideoksy-2',3'-didehydrotymidinmonohydrat og 2',3'-dideoksy-2'-fluorinosinhemihydrat

Country Status (16)

Country Link
EP (1) EP0398230B1 (no)
KR (1) KR970001160B1 (no)
CN (2) CN1027896C (no)
AT (1) ATE162528T1 (no)
AU (1) AU617614B2 (no)
BG (1) BG60517B1 (no)
DE (1) DE69031962T2 (no)
DK (1) DK0398230T3 (no)
EG (1) EG19154A (no)
ES (1) ES2113851T3 (no)
FI (1) FI95269C (no)
GR (1) GR3025984T3 (no)
HU (1) HU206628B (no)
IE (1) IE81107B1 (no)
NO (2) NO174102C (no)
PT (1) PT94040B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO920714L (no) * 1991-03-01 1992-09-02 Bristol Myers Squibb Co Tetrahydrofuran-mellomprodukt
US5221611A (en) * 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
WO1995018815A1 (en) * 1994-01-07 1995-07-13 Merrell Pharmaceuticals Inc. Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
EP1765379A4 (en) * 2004-06-17 2009-05-27 Transform Pharmaceuticals Inc PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD
JP5485140B2 (ja) 2008-04-10 2014-05-07 浜理薬品工業株式会社 5−メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
KR960001372B1 (ko) * 1986-09-24 1996-01-26 예일 유니버시티 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
CA1312599C (en) * 1988-02-16 1993-01-12 Larry Wayne Hertel 2',3'dideoxy-2',2'difluoronucleosides
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
AU5501190A (en) 1990-11-15
DK0398230T3 (da) 1998-09-21
NO933367L (no) 1990-11-16
NO933367D0 (no) 1993-09-22
PT94040A (pt) 1991-01-08
KR970001160B1 (ko) 1997-01-29
HU206628B (en) 1992-12-28
PT94040B (pt) 1996-12-31
EP0398230B1 (en) 1998-01-21
NO174102B (no) 1993-12-06
EG19154A (en) 1994-09-29
IE901734L (en) 1990-11-15
CN1109755A (zh) 1995-10-11
CN1027896C (zh) 1995-03-15
GR3025984T3 (en) 1998-04-30
CN1057443C (zh) 2000-10-18
AU617614B2 (en) 1991-11-28
HU903038D0 (en) 1990-09-28
DE69031962D1 (de) 1998-02-26
ES2113851T3 (es) 1998-05-16
KR900017591A (ko) 1990-12-19
ATE162528T1 (de) 1998-02-15
BG60517B1 (bg) 1995-07-28
NO174102C (no) 1994-03-16
FI95269B (fi) 1995-09-29
DE69031962T2 (de) 1998-09-17
NO176609B (no) 1995-01-23
FI902360A0 (fi) 1990-05-11
HUT53528A (en) 1990-11-28
CN1047676A (zh) 1990-12-12
EP0398230A3 (en) 1991-06-26
NO902148D0 (no) 1990-05-15
NO902148L (no) 1990-11-16
EP0398230A2 (en) 1990-11-22
BG92000A (bg) 1993-12-24
IE81107B1 (en) 2000-03-08
FI95269C (fi) 1996-01-10

Similar Documents

Publication Publication Date Title
HU903830D0 (en) Herbicide and biological regulator preparatives containing derivatives of salicylic aldehyde and salicylic acid as well as their sulphury analogues furthermore process for producing the active agents
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
EP0355049A3 (en) Heterocyclic compounds
CA2022392A1 (en) 4-phosphonomethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane n-oxide and water-soluble salts thereof
ES518227A0 (es) Procedimiento para preparar nuevos compuestos de cefem.
PT90021A (pt) Processo para a preparacao de derivados de benzofenona
YU47520B (sh) Postupak za dobijanje 23-(c1-c6alkiloksim)-ll-f28249 jedinjenja
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
EP0314098A3 (en) Imide derivatives, their production and use
ES2046229T3 (es) Composicion antiulcerosa.
AU617614B2 (en) Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
AU2732292A (en) Use of specific counteranions to modify the solubility of tetrazolium salts
DK638787D0 (da) Anthracyclinderivater, deres fremstilling og anvendelse
ATE61056T1 (de) Isoxazolaethanol-derivate.
WO1988004655A3 (en) Herbicidal pyridine sulfonamides
MY116824A (en) Antivaral,highly water soluble,stable,crystalline salts of 2'',3''-dideoxyinosine monohydrate,2'',3''-dideoxy-2'' ,3''-didehydrothymidine monohydrate and 2'',3''-dideoxy-2''-fluoroinosine hemihydrate
GR3007288T3 (no)
TH7375B (th) ผลึกเกลือ 2',3'-ไดดีออกซิไอโนซีน โมโนไฮเดรท 2',3'-ไดดีออกซิ-2',3'-ไดดีไฮโดรไธมิดีน?โมโนไฮเดรท และ 2',3'-ไดดีออกซิ-2'-ฟลูออโรไอโนซีน ?เฮมิไฮเดรทสำหรับต่อต้านไวรัสซึ่งละลายน้ำได้ดี?และเสถียร
TH8713A (th) ผลึกเกลือ 2',3'-ไดดีออกซิไอโนซีน โมโนไฮเดรท 2',3'-ไดดีออกซิ-2',3'-ไดดีไฮโดรไธมิดีน?โมโนไฮเดรท และ 2',3'-ไดดีออกซิ-2'-ฟลูออโรไอโนซีน ?เฮมิไฮเดรทสำหรับต่อต้านไวรัสซึ่งละลายน้ำได้ดี?และเสถียร
DE69127238D1 (de) Verfahren zur Herstellung von Pyrido[1,2-a]pyrimidinderivaten
DE69026638D1 (de) Verfahren zur Herstellung von Pyrido[1,2-a]pyrimidinderivaten
IL84482A (en) Preparation of n-phosphonomethyl-glycine n-sulphonyl amide derivatives useful as intermediates for herbicides